vs

Side-by-side financial comparison of Ambow Education Holding Ltd. (AMBO) and COMPUGEN LTD (CGEN). Click either name above to swap in a different company.

COMPUGEN LTD is the larger business by last-quarter revenue ($3.5M vs $2.8M, roughly 1.3× Ambow Education Holding Ltd.). Ambow Education Holding Ltd. runs the higher net margin — 64.2% vs -410.1%, a 474.3% gap on every dollar of revenue. On growth, Ambow Education Holding Ltd. posted the faster year-over-year revenue change (15.3% vs -61.8%).

Ambow Education Holding Ltd. is a China-focused education service provider that offers personalized learning solutions, professional career training programs, and K-12 after-school tutoring services. It partners with educational institutions and enterprises to deliver technology-integrated learning resources for learners of all age groups across mainland China.

Compugen Ltd. is a clinical-stage publicly traded predictive drug discovery and development company headquartered in Israel, with shares traded on the NASDAQ Capital Market and on the Tel Aviv Stock Exchange. Compugen was established as computational drug discovery service provider in 1993. Compugen originally acted as service provider for pharma companies, supplying its software and computational services to predict different types of biological phenomena. It had arrangements with big compan...

AMBO vs CGEN — Head-to-Head

Bigger by revenue
CGEN
CGEN
1.3× larger
CGEN
$3.5M
$2.8M
AMBO
Growing faster (revenue YoY)
AMBO
AMBO
+77.1% gap
AMBO
15.3%
-61.8%
CGEN
Higher net margin
AMBO
AMBO
474.3% more per $
AMBO
64.2%
-410.1%
CGEN

Income Statement — Q2 FY2025 vs Q2 FY2025

Metric
AMBO
AMBO
CGEN
CGEN
Revenue
$2.8M
$3.5M
Net Profit
$1.8M
$-14.5M
Gross Margin
53.3%
Operating Margin
11.9%
-475.1%
Net Margin
64.2%
-410.1%
Revenue YoY
15.3%
-61.8%
Net Profit YoY
1343.1%
-54.7%
EPS (diluted)
$0.03
$-0.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
AMBO
AMBO
CGEN
CGEN
Q2 25
$2.8M
$3.5M
Q2 24
$2.4M
$9.3M
Q1 24
$2.6M
Q2 23
$2.7M
$0
Q2 22
$16.4M
Net Profit
AMBO
AMBO
CGEN
CGEN
Q2 25
$1.8M
$-14.5M
Q2 24
$123.0K
$-9.4M
Q1 24
$7.3M
Q2 23
$-1.0M
$-18.6M
Q2 22
$-11.0M
Gross Margin
AMBO
AMBO
CGEN
CGEN
Q2 25
53.3%
Q2 24
55.6%
60.5%
Q1 24
17.9%
Q2 23
44.7%
Q2 22
9.2%
Operating Margin
AMBO
AMBO
CGEN
CGEN
Q2 25
11.9%
-475.1%
Q2 24
2.7%
-128.5%
Q1 24
Q2 23
-27.7%
Q2 22
-13.7%
Net Margin
AMBO
AMBO
CGEN
CGEN
Q2 25
64.2%
-410.1%
Q2 24
5.1%
-101.4%
Q1 24
284.0%
Q2 23
-36.7%
Q2 22
-67.1%
EPS (diluted)
AMBO
AMBO
CGEN
CGEN
Q2 25
$0.03
$-0.16
Q2 24
$0.00
$-0.10
Q1 24
$89505618.00
Q2 23
$-0.02
$-0.21
Q2 22
$-0.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
AMBO
AMBO
CGEN
CGEN
Cash + ST InvestmentsLiquidity on hand
$4.1M
$35.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$8.6M
$50.3M
Total Assets
$23.2M
$106.5M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
AMBO
AMBO
CGEN
CGEN
Q2 25
$4.1M
$35.3M
Q2 24
$1.6M
$44.6M
Q1 24
$39.3M
Q2 23
$6.9M
$21.6M
Q2 22
$9.2M
Stockholders' Equity
AMBO
AMBO
CGEN
CGEN
Q2 25
$8.6M
$50.3M
Q2 24
$6.6M
$58.3M
Q1 24
$65.6M
Q2 23
$7.4M
$62.0M
Q2 22
$9.4M
Total Assets
AMBO
AMBO
CGEN
CGEN
Q2 25
$23.2M
$106.5M
Q2 24
$17.6M
$110.2M
Q1 24
$121.3M
Q2 23
$28.8M
$77.1M
Q2 22
$136.4M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
AMBO
AMBO
CGEN
CGEN
Operating Cash FlowLast quarter
$-18.6M
Free Cash FlowOCF − Capex
$-18.8M
FCF MarginFCF / Revenue
-530.8%
Capex IntensityCapex / Revenue
6.5%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
AMBO
AMBO
CGEN
CGEN
Q2 25
$-18.6M
Q2 24
$39.7M
Q1 24
Q2 23
$-18.6M
Q2 22
Free Cash Flow
AMBO
AMBO
CGEN
CGEN
Q2 25
$-18.8M
Q2 24
$39.7M
Q1 24
Q2 23
$-18.6M
Q2 22
FCF Margin
AMBO
AMBO
CGEN
CGEN
Q2 25
-530.8%
Q2 24
428.3%
Q1 24
Q2 23
Q2 22
Capex Intensity
AMBO
AMBO
CGEN
CGEN
Q2 25
6.5%
Q2 24
0.4%
Q1 24
Q2 23
Q2 22

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons